This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2012 Jul;12(7):502-3.

doi: 10.1016/S1473-3099(12)70137-8.

Linezolid for multidrug-resistant tuberculosis

Kwok-Chiu Chang¹, Chi-Chiu Leung, Charles L Daley

Affiliations

PMID: 22742623
DOI: 10.1016/S1473-3099(12)70137-8

Linezolid for multidrug-resistant tuberculosis

Kwok-Chiu Chang et al. Lancet Infect Dis. 2012 Jul.

. 2012 Jul;12(7):502-3.

doi: 10.1016/S1473-3099(12)70137-8.

Authors

Kwok-Chiu Chang¹, Chi-Chiu Leung, Charles L Daley

Affiliation

¹ Tuberculosis and Chest Service, Department of Health, Hong Kong, China. kc_chang@dh.gov.hk

PMID: 22742623
DOI: 10.1016/S1473-3099(12)70137-8

No abstract available

PubMed Disclaimer

Comment in

Linezolid for multidrug-resistant tuberculosis - authors' reply.
Chang KC, Leung CC, Daley CL. Chang KC, et al. Lancet Infect Dis. 2013 Jan;13(1):16-7. doi: 10.1016/S1473-3099(12)70272-4. Lancet Infect Dis. 2013. PMID: 23257227 No abstract available.
Linezolid for multidrug-resistant tuberculosis.
Cox H, Ford N, Hughes J, Goemaere E. Cox H, et al. Lancet Infect Dis. 2013 Jan;13(1):16. doi: 10.1016/S1473-3099(12)70299-2. Lancet Infect Dis. 2013. PMID: 23257228 No abstract available.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science